A biotech company is using dogs and AI-powered breath analysis to improve early cancer detection through non-invasive at-home ...
Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity – the financial stress and hardship that ...
Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision ...
ClearNote Health secures $52 million to scale early cancer detection and expand global clinical and commercial operations.
Vietnam Investment Review on MSN
FDA grants breakthrough device designation to Gene Solutions SPOT MAS 10 multi cancer screening test
SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, today announced that the U.S.
You can read Part 1 here and Part 3 here.
Proceeds will support continued commercial expansion, operational scale-up, clinical study execution, and product development * Clinical oncology ...
Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity—the financial stress and hardship that can ...
Researchers have identified a distinct saliva microbiome signature linked to esophageal cancer, raising the possibility of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results